Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United K…
$0.31+0.82%
报价 2026-11-13
市值
$49.1M
EV
$15.6M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -86.7%
$0.24$2.31
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| MREOMereo BioPharma Group plc | $49.1M | +0.8% | – | 0% | – | – | – | |
| ATNMActinium Pharmaceuticals, Inc. | $51.6M | +3.1% | +12800.0% | 101.1% | 4.0x | 0.8x | – | |
| IBIOiBio, Inc. | $51.6M | -4.0% | -50.0% | -160% | – | – | – | |
| APLMApollomics, Inc. | $51.5M | +2.2% | +1230.0% | 100% | – | – | – | |
| RNXTRenovoRx, Inc. | $50.2M | -10.3% | +146.2% | 84.4% | – | – | – | |
| PDSBPDS Biotechnology Corporation | $48.7M | -11.0% | +2700.0% | 0% | – | – | – | |
| INKTMiNK Therapeutics, Inc. | $47.7M | -2.0% | – | 0% | – | – | – | |
| HOWLWerewolf Therapeutics, Inc. | $47.6M | +0.0% | +232.0% | 86.4% | – | – | – | |
| HYFTMindWalk Holdings Corp. | $47.1M | -1.0% | – | 60.8% | – | – | – | |
| 同行中位数 | – | – | +731.0% | 72.6% | 4.0x | 0.8x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。